Health Policy and High-Tech Industrial Development
Edward Elgar Publishing Ltd (Verlag)
978-1-84376-757-2 (ISBN)
Many countries and regions are actively promoting high technology industries as a means of stimulating the economy. The authors point out that these efforts are not only encouraging economic development, but they also reduce an economy's vulnerability to the negative consequences of world trade. By weaving together the fields of health economics, industrial organisation and industrial development, this book describes the benefits of promoting a country's health industry as a way of stimulating its high-technology industrial capacity.
The authors illustrate that the development of a country's health industry not only improves the country's health status, but also promotes an industry with relatively stable, high-wage employment, creates the potential for exporting goods and services, and produces scientific spillovers that will favourably impact other high-technology industries.
Health Policy and High-Tech Industrial Development will be of great interest to health policy analysts by showing that health policies have broader implications than merely affecting health systems. Health economists should consider the advantages of viewing a country's health system not only as a unique industry that produces both health care and high-technology goods and services, but that also possesses the ability to stimulate development of a broader array of high-technology industries. Development and industrial economists and policymakers will also see the health sector from this different and innovative perspective.
Edited by Marco R. Di Tommaso, University of Bologna, Italy and Stuart O. Schweitzer, Professor of Health Policy and Management, Associate Director, Research Program on Pharmaceutical Economics and Policy, Fielding School of Public Health, University of California at Los Angeles, US
Contents:
Part I: An Overview
Introduction: Why Apply Industrial Policy to the Health Industry?
1. The Health Industry Model: New Roles for the Health Industry
Part II: The Macro View
2. Healthy Governance: Economic Policy and the Health Industry Model
3. Control, Competition and Co-operation in European Health Systems: Points of Contact Between Health Policy and Industrial Policy
4. A Hedonic Model of Pricing of Innovative Pharmaceuticals
Part III: The Micro View
5. Recent Developments in Universities Regarding Intellectual Capital and Intellectual Property
6. Intangible Assets in the European Health Industry: The Case of the Pharmaceutical Sector
7. Benchmarking Hospital Costs in the UK: Increasing Efficiency and Driving Innovation in the Healthcare Industry?
Part IV: The Intermediate View
8. The Geography of Intangibles: The Case of the Health Industry
9. Clustering in the Biotechnology Industry
10. Spillovers of University–High-Tech Industry Alliances
11. Multinational Enterprises and High-Tech Clusters in the Health Industry: Some Preliminary Results in Italy
12. High-Technology Clusters in France: Two Unusual Models – An Empirical Study
Index
| Erscheint lt. Verlag | 29.3.2005 |
|---|---|
| Verlagsort | Cheltenham |
| Sprache | englisch |
| Maße | 156 x 234 mm |
| Themenwelt | Medizin / Pharmazie ► Pharmazie |
| Technik | |
| Wirtschaft ► Volkswirtschaftslehre | |
| ISBN-10 | 1-84376-757-0 / 1843767570 |
| ISBN-13 | 978-1-84376-757-2 / 9781843767572 |
| Zustand | Neuware |
| Informationen gemäß Produktsicherheitsverordnung (GPSR) | |
| Haben Sie eine Frage zum Produkt? |
aus dem Bereich
